N-acetylcysteine in chronic blepharitis.

Cornea

Ophthalmology Department, SSK Okmeydani Training Hospital, Kayisdagi cad., Eston camlievler sitesi A8D17, Sahilcami, Içerenköy 81120, Istanbul, Turkey.

Published: March 2002

Purpose: To investigate the effects of N-acetylcysteine (NAC) in chronic posterior blepharitis.

Methods: This was a prospective randomized, controlled study that included 79 eyes of 40 patients with chronic posterior blepharitis. Routine ophthalmologic examination, Schirmer-1 test, fluorescein break-up time (FBUT), and mucous fern tests were carried out during the first visit of all patients. A topical steroid, topical antibiotic, and artificial tears were started in 36 eyes of 18 patients. The therapy group (43 eyes of 22 patients) was administered three daily doses of 100 mg oral NAC. All patients were examined weekly for 1 to 4 months (average, 24 +/- 0.7). A Schirmer-1 test and FBUT were administered at every visit, but mucous fern tests were administered every two weeks. The results of the first and last Schirmer-1 tests, FBUT, and mucous fern test were compared between the therapy and control groups. Student's t and Mann-Whitney U tests were used for statistical analysis.

Results: FBUT was significantly increased (p < 0.0001), and the mucous fern pattern was also significantly improved (p = 0.0096) in the therapy group.

Conclusion: NAC is thought to increase FBUT and improve mucous fern pattern by blocking lipid peroxidation in chronic blepharitis.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00003226-200203000-00007DOI Listing

Publication Analysis

Top Keywords

mucous fern
20
eyes patients
12
chronic blepharitis
8
chronic posterior
8
schirmer-1 test
8
fbut mucous
8
fern tests
8
fern pattern
8
patients
5
fbut
5

Similar Publications

[Mucosal lichen planus-a diagnostic and therapeutic challenge].

Dermatologie (Heidelb)

September 2022

Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Deutschland.

Mucosal lichen planus (MLP) is a chronic inflammatory disease of the mucosa. This condition can affect the mouth, esophagus, pharynx, genitalia, anus, and conjunctiva. This disease shows a tendency to chronicity with phases of relapses for a duration of 3-10 years.

View Article and Find Full Text PDF

Unlabelled: Recently, there has been an increase in the number of patients with allergic rhinitis (AR) and the number of publications devoted to this problem is increasing. The main etiological factors of AR are pollen of trees, meadow and weeds, as well as mold spores, household allergens and epidermis of animals. Epidemiological studies have found that the prevalence and structure of AR are influenced by regional characteristics, such as the climatic and geographical and social characteristics of the region, and successively therapeutic and preventive algorithms in AR are also different.

View Article and Find Full Text PDF

Background: Irritable bowel syndrome (IBS) is the most prevalent functional gastrointestinal disorder (FGID) leading to substantial reduction in quality of life. This study was undertaken to assess the relationship between diet and prevalence of IBS in female adolescents.

Methods: In this cross-sectional study, data were examined on 988 adolescent girls from different areas of Mashhad and Sabzevar cities, Iran.

View Article and Find Full Text PDF
Article Synopsis
  • Dryopteris crassirhizoma (DC) exhibits multiple pharmacological effects, including anti-inflammatory properties, which prompted a study to analyze its impact on allergic asthma using a mouse model.
  • The study found that DC reduced inflammatory cell levels and collagen deposition in the lungs, along with modulating cytokine levels by increasing Th1 cytokines and decreasing Th2 cytokines.
  • DC treatment also inhibited the activation of NF-κB signaling pathways and lowered IgE levels, indicating its potential as an anti-inflammatory agent for allergic asthma management.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!